Theravance Biopharma (TBPH) EBITDA Margin Growth (3y) (2016 - 2026)
Theravance Biopharma (TBPH) EBITDA Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
15,783.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
15,783.00 |
| Dec 31, 2025 |
19,905.00 |
| Sep 30, 2025 |
-734,300.00 |
| Jun 30, 2025 |
28,358.00 |
| Mar 31, 2025 |
95,067.00 |
| Dec 31, 2024 |
32,674.00 |
| Sep 30, 2024 |
19,271.00 |
| Jun 30, 2024 |
29,006.00 |
| Mar 31, 2024 |
47,883.00 |
| Dec 31, 2023 |
37,286.00 |
| Sep 30, 2023 |
34,759.00 |
| Jun 30, 2023 |
30,433.00 |
| Mar 31, 2023 |
530,100.00 |
| Dec 31, 2022 |
-8,959.00 |
| Sep 30, 2022 |
783,177.00 |
| Jun 30, 2022 |
-81.00 |
| Mar 31, 2022 |
31,829.00 |
| Dec 31, 2021 |
2,212.00 |
| Sep 30, 2021 |
19,387.00 |
| Jun 30, 2021 |
-23,340.00 |
